Adapting Changing Talk: Online (CHATO) to CHATO-Inclusive
ConditionDementia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Kansas Medical Center
About this trial
This study will adapt and test online interactive training for nursing home staff that improves staff communication and reduces behavioral symptoms of persons with dementia that they care for. This research will adapt and test communication training to meet the needs of nursing homes to improve dementia care.
Eligibility criteria
Qualifiers
Medicare certified NHs (N=40) caring for residents diagnosed with AD/ADRD.
CNAs, nurses, and other direct care staff who are permanent employees of participating NHs and who provide direct care at least 8 hours weekly will complete the CHATO-I training, available by URL link.
All staff will be encouraged to participate as high staff participation is desired to achieve facility-wide communication change. NHs will provide the number of eligible staff participants.
Data for residents in participating NHs with AD/ADRD documented on the MDS Active Diagnoses list will be included in the analyses as well as MDS data for: age, sex, race and ethnicity, frailty (MDS-CHESS scale), and level of cognitive function (MDS Cognitive Performance Scale).
Disqualifiers
NHs serving 25% of residents admitted prior to age 65 will be excluded (screening out NHs serving primarily younger persons with serious mental illnesses).
CNAs, nurses, and other direct care staff who do not meet the inclusion criteria.
Resident data excluded from MDS includes active psychiatric diagnoses (bipolar disorder, major depressive episode, schizophrenia or schizoaffective disorder, mood disorder with psychotic features, psychotic symptoms, hallucinations, or delusions); terminal illness (on hospice); and lack of response to staff (MDS section B).
Trial design
Treatments tested in this trial
- CHATO-I
Treatment groups
1,200 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
University of Kansas Medical Center
Lead sponsor
University of Oklahoma
Collaborator
University of Iowa
Collaborator
Source ClinicalTrials.gov